To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

The BD FACSVerse™ flow cytometer was engineered from the ground up to offer remarkable performance, flexibility, and ease of operation for research applications using up to 10 parameters.

Lung cancer is the commonest form of the disease, with 2.5 million people diagnosed in 2022 ...